Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+282.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+282.9%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
56.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 133.25% |
| Q3 2025 | -5.10% |
| Q2 2025 | -2.15% |
| Q1 2025 | -13.46% |
| Q4 2024 | -2.05% |
| Q3 2024 | 3.07% |
| Q2 2024 | -16.89% |
| Q1 2024 | -15.56% |
| Q4 2023 | 14.07% |
| Q3 2023 | -12.10% |
| Q2 2023 | -12.22% |
| Q1 2023 | -17.47% |
| Q4 2022 | 2.37% |
| Q3 2022 | -31.87% |
| Q2 2022 | -48.87% |
| Q1 2022 | 35.15% |
| Q4 2021 | -80.24% |
| Q3 2021 | 21.44% |
| Q2 2021 | -42.41% |
| Q1 2021 | 0.00% |